Clover Health Investments Corp (CLOV) Stock: Do Analysts Think You Should Accumulate?

Wall Street is positive on Clover Health Investments Corp (CLOV). On average, analysts give Clover Health Investments Corp a Buy rating. The average price target is $3.5, which means analysts expect the stock to gain by 18.64% over the next twelve months. That average ranking earns Clover Health Investments Corp an Analyst Rating of 13, which is better than 13% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating CLOV a Buy today. Find out what this means to you and get the rest of the rankings on CLOV!

See Full CLOV Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Clover Health Investments Corp Stock Today?

Clover Health Investments Corp (CLOV) stock is trading at $2.95 as of 10:12 AM on Friday, Aug 19, a loss of -$0.19, or -6.05% from the previous closing price of $3.14. The stock has traded between $2.95 and $3.10 so far today. Volume today is less active than usual. So far 1,474,972 shares have traded compared to average volume of 7,322,546 shares. Click Here to get the full Stock Report for Clover Health Investments Corp stock.